Abstract.
A 26-year-old woman who had been treated for nonmetastatic gestational trophoblastic tumor with three courses of methotrexate with folinic acid rescue and had been lost to follow up for 4 years was referred with the fractional curettage diagnosis of choriocarcinoma that had been performed for abnormal vaginal bleeding. Her serum beta human chorionic gonadotropin (βhCG) was 706,000 mIU/mL and there were multiple pulmonary metastatic foci. The uterus was 12 weeks pregnant-size and a 6×6-cm tumor mass was seen within the anterior uterine wall at ultrasonography. Following total abdominal hysterectomy etoposide, methotrexate, actinomycin-D, vincristine and cyclophosphamide (EMA/CO) regimen was given. Whole brain radiation of 30 Gy in 3 weeks for brain metastasis, discovered in magnetic resonance imaging was given after the first course. Since serum βhCG levels plateaued after three courses of chemotherapy and multiple pulmonary metastases persisted, treatment was shifted to etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP) regimen. She was in remission after three courses of chemotherapy.
Similar content being viewed by others
References
Altintas A, Vardar MA (2001) Central nervous system involvement in gestational trophoblastic neoplasia. Eur J Gynaecol Oncol 22:154–156
Ayhan A, Ergeneli MH, Yüce K, Yapar EG, Kisnisci AH (1990) Pregnancy after chemotherapy for gestational trophoblastic disease. J Reprod Med 35:522–524
Ayhan A, Tuncer ZS, Tanir M, Erbengi A (1996) Central nervous system involvement in gestational trophoblastic neoplasia. Acta Obstet Gynecol Scand 75:548–550
Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD (1997) EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15:2636–2643
Kim SJ, Bae SN, Kim JH, Kim CJ, Jung JK (1998) Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 71:247–253
Lehman E, Gershenson DM, Burke TW, Levenback C, Silva EG, Morris M (1994) Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol 12:2737–2742
Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18:854–859
Suzuka K, Matsui H, Iitsuka Y, Yamazawa K, Seki K, Sekiya S (2001) Adjuvant hysterectomy in low-risk gestational trophoblastic disease. Obstet Gynecol 97:431–434
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilgin, T., Ozan, H., Özuysal, S. et al. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-d, etoposide, cisplatin (EMA/EP). Arch Gynecol Obstet 269, 159–160 (2004). https://doi.org/10.1007/s00404-002-0422-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-002-0422-4